Dennis A Revicki

Summary

Affiliation: MEDTAP International
Country: USA

Publications

  1. Revicki D, Paramore L, Sommerville K, Swann A, Zajecka J. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes. J Clin Psychiatry. 2003;64:288-94 pubmed
    ..88). Divalproex is associated with lower 12-week outpatient costs compared with olanzapine. Divalproex and olanzapine have similar short-term effects on clinical or HRQL outcomes in bipolar disorder subjects. ..
  2. Revicki D, Sorensen S, Maton P, Orlando R. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis. 1998;16:284-91 pubmed
    ..83). Omeprazole treatment significantly reduced persistent reflux-related symptoms and normalized psychological well-being compared with ranitidine in poorly responsive symptomatic patients with GERD. ..
  3. Revicki D, Rentz A, Dubois D, Kahrilas P, Stanghellini V, Talley N, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004;13:833-44 pubmed
    ..0001) and patients (p = 0.0004). The findings of this study indicate that the GCSI is a reliable and valid instrument for measuring symptom severity in patients with gastroparesis. ..
  4. Revicki D, Gershon R. Work-related stress and psychological distress in emergency medical technicians. J Occup Health Psychol. 1996;1:391-6 pubmed
    ..Work-related stress was strongly related to psychological distress. Changes in work-related stress were significantly related to changes in psychological distress. Findings support the work-related stress, psychological distress model. ..
  5. Revicki D, Moyle G, Stellbrink H, Barker C. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. AIDS. 1999;13:851-8 pubmed
    ..05). Patients on triple combination therapy maintained their quality of life over 48 weeks compared with significant decreases in the quality of life for ddC/ZDV combination therapy. ..
  6. Revicki D, Swartz C, Wu A, Haubrich R, Collier A. Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3. Antivir Ther. 1999;4:35-44 pubmed
    ..The HRQL findings are concordant with improved survival and reduced clinical progression of HIV infection found in this study. ..
  7. Revicki D, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy N, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res. 2000;9:887-900 pubmed
  8. Revicki D, Crawley J, Zodet M, Levine D, Joelsson B. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1621-30 pubmed
    ..We evaluated the association between complete resolution of heartburn symptoms and functioning and well-being in three samples of patients with GERD...
  9. Revicki D, Zodet M, Joshua Gotlib S, Levine D, Crawley J. Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity. Health Qual Life Outcomes. 2003;1:73 pubmed